NOVAMECHANICS LIMITED

Their core work

NovaMechanics is a Cyprus-based SME specializing in computational modelling and nanoinformatics — they build software tools and predictive models that help industry and regulators assess the safety and risk of nanomaterials without relying solely on expensive lab testing. Their core capability is translating complex nanotoxicology data into actionable risk assessments, grouping strategies, and safe-by-design frameworks. They also apply their computational expertise to adjacent fields like drug discovery (cancer immunotherapy) and natural product chemistry, though nanomaterial safety remains their bread and butter.

What they specialise in

How they've shifted over time

NovaMechanics started (2016–2019) with foundational nanosafety research — nanotoxicity testing, bioinformatics, genotoxicity, and policy/regulation work (NANOGENTOOLS, NanoCommons). From 2019 onward, they shifted decisively toward applied industrial implementation: safe-by-design manufacturing, on-line production screening, composite coatings, and feedback control systems (SABYDOMA, DIAGONAL). Simultaneously, they diversified into biomedical applications like cancer immunotherapy (CAPSTONE), suggesting a deliberate strategy to apply their computational modelling platform beyond nanomaterials into broader life sciences.

NovaMechanics is evolving from a nanosafety research partner into a computational platform company that applies predictive modelling across nanomaterials, manufacturing, and drug discovery.

How they like to work

NovaMechanics operates primarily as a specialist partner (8 of 10 projects), contributing computational and modelling expertise to large consortia, but they have demonstrated coordination capability in two projects (NanoSolveIT, CompSafeNano) — both in their core nanoinformatics domain. With 125 unique partners across 39 countries, they maintain a remarkably wide network for an SME of their size, indicating they are a sought-after specialist rather than a company that repeatedly works with the same small circle. This breadth makes them a strong connector for new consortium builders in the nanosafety space.

Exceptionally wide network for an SME: 125 unique consortium partners spread across 39 countries, covering most of the EU and beyond. Their network is concentrated in the European nanosafety and nanoinformatics research community, with no obvious geographic bias toward a single region.

What sets them apart

NovaMechanics occupies a rare niche as a computational SME that bridges the gap between nanomaterial science and regulatory compliance — most nanosafety players are either large research institutes or testing labs, not software-driven modelling companies. Their ability to coordinate EU projects (NanoSolveIT at over EUR 1M) while remaining an SME demonstrates both technical credibility and project management maturity. For consortium builders, they offer something hard to find: a private company with deep regulatory domain knowledge that can deliver computational tools rather than just academic papers.

Highlights from their portfolio

• NanoSolveIT
  Their largest project (EUR 1,052,350) and a coordination role — built a cloud platform for nanomaterial risk prediction, establishing them as a nanoinformatics leader.
• SABYDOMA
  Marks their shift toward industrial application with real-world manufacturing integration: on-line screening, composite coatings, and feedback control systems.
• CAPSTONE
  Unexpected diversification into cancer immunotherapy and drug discovery, applying their computational platform well beyond nanomaterials.